David Holmes, M.D., professor of medicine, Mayo Clinic College of Medicine and consultant, Department of Internal ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
April 15, 2016
April 8, 2016 — New data from an ongoing post-marketing study confirm the safety profile of Xarelto (rivaroxaban) was ...
April 08, 2016
AliveCor, Inc., the leader in FDA-cleared electrocardiogram (ECG) technology for mobile devices, announced today the ...
March 28, 2016Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
March 17, 2016 — Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being ...
March 17, 2016
March 16, 2016 — The Valley Hospital in Ridgewood, N.J., is one of 15 U.S. sites currently enrolling patients in a ...
March 16, 2016
March 14, 2016 — Biotronik announced that its BioMonitor 2 heart monitor is now available for patients in the United ...
March 14, 2016Sponsored Content
Blog
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
November 13, 2023
March 11, 2016 — Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the Blazer Open ...
March 11, 2016
February 18, 2016 — AtriCure Inc. announced that the first patient was enrolled and treated at PinnacleHealth Hospitals ...
February 18, 2016
January 6, 2016 — A new study determined that the Watchman left atrial appendage closure device is more cost-effective ...
January 06, 2016Sponsored Content
Blog
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
November 02, 2023
December 22, 2015 — In 2015, results from the ITALIC and CvLPRIT trials, along with studies examining lifestyle factors ...
December 22, 2015
December 17, 2015 — The ROCKET AF Clinical Trial Executive Committee announced its secondary analysis of the phase III ...
December 17, 2015
December 8, 2015 — Biotronik announced the first patient enrollments to the B3 clinical trial. The study will evaluate ...
December 08, 2015Sponsored Content
Blog | ECG
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
August 24, 2022
November 24, 2015 — Biosense Webster announced it has acquired Coherex Medical Inc., a privately held medical device ...
November 24, 2015
November 20, 2015 — Boston Scientific announced the first implants of the Watchman FLX left atrial appendage closure ...
November 20, 2015
November 11, 2015 — Brigham and Women’s Hospital in Boston and Boehringer Ingelheim announced the results of a new ...
November 11, 2015